Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey

被引:32
作者
Abitbol, Vered [1 ]
Lahmek, Pierre [3 ]
Buisson, Anne [2 ]
Olympie, Alain [2 ]
Poupardin, Cecile [4 ]
Chaussade, Stanislas [1 ]
Lesgourgues, Bruno [4 ]
Nahon, Stephane [4 ]
机构
[1] Cochin Hosp, APHP, Dept Gastroenterol, F-75014 Paris, France
[2] Assoc Francois Aupetit, Limeil Brevannes, France
[3] Emile Roux Hosp, APHP, Limeil Brevannes, France
[4] GHI Le Raincy Montfermeil, Dept Gastroenterol & Hepatol, Montfermeil, France
关键词
adherence; complementary and alternative medicines; compliance; Crohn's disease; quality of life; ulcerative colitis; ADHERENCE; CARE; PREDICTORS; MEDICATION; MANAGEMENT; QUESTIONNAIRE;
D O I
10.1097/MEG.0000000000000040
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundComplementary and alternative medicines (CAM) are widely used by patients with inflammatory bowel disease (IBD). Few data have been published on the impact of CAM on the quality of life (QOL).AimsThe aim of the study was to describe CAM use in French patients with IBD, identify characteristics associated with CAM use, and assess the impact of CAM on the QOL.MethodsWe conducted an internet survey on CAM through the French IBD patient's association website. Patients had to answer a questionnaire (LimeSurvey application) about sociodemography, IBD treatment, CAM type, socioeconomic data, and QOL using the Short IBD Questionnaire (SIBDQ). Patients noted the impact of CAM on their symptoms and on their QOL on a scale of 0-100. CAM users and nonusers were compared by univariate and multivariate analyses.ResultsA total of 936 IBD patients responded and 767 (82.4%) filled up the whole questionnaire: 503 reported CAM use and 172 had never used. The types of CAM reported were diet-based (30.7%), body-based (25.1%), homeopathic or traditional medicine (19.6%), naturopathy (15.2%), and mind-body medicine (9.1%). The gastroenterologist was aware of CAM use in only 46% of patients. CAM users were more likely to have ulcerative colitis [odds ratio (OR)=1.78, P=0.018], clinical remission (OR=1.42, P=0.06), high level of education (OR=1.51, P=0.02), poor observance (OR=1.81, P=0.017), or to have terminated conventional treatment (OR=2.03, P=0.003). CAM users tend to have higher rates of SIBDQ scores, greater than 50 (OR=1.57, P=0.06). Improvement in symptoms and QOL was reported with all CAM types except mind medicine.ConclusionCAM use is widespread among IBD patients. CAM users report improvement in symptoms and QOL, but they tend to stop their conventional treatment. Better information about CAM might improve adherence to conventional treatment.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 50 条
  • [31] Perceptions on the surgical treatment of inflammatory bowel disease in Spain. Results of a national survey
    Sanchez-Guillen, Luis
    Blanco-Antona, Francisco
    Millan-Scheiding, Monica
    CIRUGIA ESPANOLA, 2016, 94 (10): : 560 - 568
  • [32] Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort
    Greuter, Thomas
    Porchet, Frederic
    Braga-Neto, Manuel B.
    Rossel, Jean-Benoit
    Biedermann, Luc
    Schreiner, Philipp
    Scharl, Michael
    Schoepfer, Alain M.
    Safroneeva, Ekaterina
    Straumann, Alex
    Rogler, Gerhard
    Vavricka, Stephan R.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (10) : 1196 - 1207
  • [33] The use of complementary and alternative medicine in Iceland: Results from a national health survey
    Gunnarsdottir, Thora Jenny
    Orlygsdottir, Brynja
    Vilhjalmsson, Runar
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2020, 48 (06) : 602 - 608
  • [34] Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease
    Garcia-Planella, Esther
    Marin, Laura
    Domenech, Eugeni
    Bernal, Isabel
    Manosa, Miriam
    Zabana, Yamile
    Gassull, Miquel A.
    MEDICINA CLINICA, 2007, 128 (02): : 45 - 48
  • [35] Health related quality of life in inflammatory bowel disease: The impact of surgical therapy
    Umanskiy, Konstantin
    Fichera, Alessandro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (40) : 5024 - 5034
  • [36] Review on Efficacy and Health Services Research Studies of Complementary and Alternative Medicine in Inflammatory Bowel Disease
    Joos, Stefanie
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2011, 17 (06) : 403 - 409
  • [37] Systematic Review of Complementary and Alternative Medicine Treatments in Inflammatory Bowel Diseases
    Langhorst, J.
    Wulfert, H.
    Lauche, R.
    Klose, P.
    Cramer, H.
    Dobos, G. J.
    Korzenik, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (01) : 86 - 106
  • [38] The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products
    Rawsthorne, Patricia
    Clara, Ian
    Graff, Lesley A.
    Bernstein, Kylie I.
    Carr, Rachel
    Walker, John R.
    Ediger, Jason
    Rogala, Linda
    Miller, Norine
    Bernstein, Charles N.
    GUT, 2012, 61 (04) : 521 - 527
  • [39] Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD)
    Mousavi, Taraneh
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (07) : 865 - 888
  • [40] Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey
    Ghosh, Subrata
    Mitchell, Rod
    JOURNAL OF CROHNS & COLITIS, 2007, 1 (01) : 10 - 20